Have any questions? 706-721-6582 or cts@augusta.edu
This is a clinical research study to find out if ranibizumab (brand name Lucentis®) is safe and has beneficial effects in the treatment of retinopathy of prematurity (ROP), a condition of abnormal blood vessel (arteries and veins) development in the eyes of premature babies.